Texas Children's Hospital Implements Omnicell Performance Center and Upgrades Medication Management Automation

MOUNTAIN VIEW, Calif., Nov. 8, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Texas Children's Hospital, located in Houston, Texas, selected Omnicell^® Performance Center™ to improve pharmacy operations and optimize medication management across its health system. Texas Children's is also upgrading its Omnicell automated dispensing cabinet technology to the latest-generation XT series to further streamline medication management in patient care areas.

Ranked as the #4 Best Children's Hospital in the country by U.S. News & World Report, Texas Children's understands that better management of medications is critical to hospital sustainability, efficiency, and safe patient care. "Importantly, early investment in an innovative technology is only part of the story. The other component is how the organization takes advantage of the possibilities the new technology provides within," said Eric Williams, chief medical information officer at Texas Children's Hospital.

Omnicell Performance Center combines enterprise software with ongoing expert services to proactively monitor pharmacy operations and recommend actionable insights, leading to improved operational efficiency, regulatory compliance, and patient outcomes. Leveraging the power of predictive intelligence and real-time inventory tracking, Performance Center helps reduce inventory spend, manage medication shortage and expiration risk, and locate medications across a health system.

"Predictive modeling and machine learning are powerful tools that are just beginning to impact the healthcare landscape. Performance Center leverages these tools alongside industry expertise, which we expect will help identify unrealized efficiencies within our health system that will ultimately enhance patient care," Williams said.

In addition to adopting Performance Center, Texas Children's will be expanding upon Omnicell's Unity platform by adding diversion analytics and Closed Loop Dose Accountability, part of Omnicell's interoperability with the Epic electronic health record system. These solutions help improve medication safety and security. The health system is replacing existing automated dispensing cabinets with the XT series, which will be implemented across the Main Campus, West Campus, The Woodlands, and the Pavilion for Women. Increased medication storage capacity of XT allows enhanced access to medications on patient floors, decreases the need to dispense standardized medications from pharmacy areas, and streamlines the chain of custody during medication management.

"As a rapidly expanding health system, we are constantly striving for excellence in care across our facilities," said Gee Mathen, assistant director of Pharmacy Applications and Technical Services at Texas Children's Hospital. "We believe that equipping our teams and providers with consistent, safe products not only improves our medication management processes but also supports safety all the way to the patient. The addition of Performance Center will proactively monitor our data to find opportunities for improving our operations."

"We're excited to be adding a specialty pharmacy to our health system, which will bring additional value to our patients and support them throughout the continuum of care," said Jeff Wagner, PharmD, MPH, BCPS, director of pharmacy at Texas Children's Hospital. "The enhanced visibility afforded by Performance Center will help us better manage inventory and enable a higher level of control and transparency for high-cost medications."

"We're proud to be expanding our partnership with such a prestigious health system as Texas Children's," said Nhat H. Ngo, executive vice president, Strategy and Business Development, at Omnicell. "With our new services and technology offerings, we look forward to helping them bring the same level of excellence to managing their medication supply chain and distribution systems as they have in place for patient care."

About Texas Children's Hospital

Texas Children's Hospital, a not-for-profit health care organization, is committed to creating a healthier future for children and women throughout the global community by leading in patient care, education and research. Consistently ranked as the best children's hospital in Texas, and among the top in the nation, Texas Children's has garnered widespread recognition for its expertise and breakthroughs in pediatric and women's health. The hospital includes the Jan and Dan Duncan Neurological Research Institute; the Feigin Tower for pediatric research; Texas Children's Pavilion for Women, a comprehensive obstetrics/gynecology facility focusing on high-risk births; Texas Children's Hospital West Campus, a community hospital in suburban West Houston; and Texas Children's Hospital The Woodlands, the first hospital devoted to children's care for communities north of Houston. The organization also created Texas Children's Health Plan, the nation's first HMO for children; Texas Children's Pediatrics, the largest pediatric primary care network in the country; Texas Children's Urgent Care clinics that specialize in after-hours care tailored specifically for children; and a global health program that's channeling care to children and women all over the world. Texas Children's Hospital is affiliated with Baylor College of Medicine. For more information, go to www.texaschildrens.org. Get the latest news by visiting the online newsroom and Twitter at twitter.com/texaschildrens.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Over 4,000 customers worldwide use Omnicell^® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.

Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.

For more information about Omnicell, Inc. please visit www.omnicell.com.

OMCL-G

Editor's Notes:

1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
3. All other brand or product names may be trademarks or registered trademarks of their respective companies.

SOURCE Omnicell, Inc.

Related Links

http://www.omnicell.com